Divergent roles of the Hippo pathway in the pathogenesis of idiopathic pulmonary fibrosis: tissue homeostasis and fibrosis
Authors:
Open Access
- 21 September 2023
- journal article
- review article
- Published by Springer Nature in Inflammation and Regeneration
- Vol. 43 (1) , 1-12
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive aging-related lung disease with a poor prognosis. Despite extensive research, the cause of IPF remains largely unknown and treatment strategies are limited. Proposed mechanisms of the pathogenesis of IPF are a combination of excessive accumulation of the extracellular matrix and dysfunctional lung tissue regeneration. Epithelial cell dysfunction, in addition to fibroblast activation, is considered a key process in the progression of IPF. Epithelial cells normally maintain homeostasis of the lung tissue through regulated proliferation, differentiation, cell death, and cellular senescence. However, various stresses can cause repetitive damage to lung epithelial cells, leading to dysfunctional regeneration and acquisition of profibrotic functions. The Hippo pathway is a central signaling pathway that maintains tissue homeostasis and plays an essential role in fundamental biological processes. Dysregulation of the Hippo pathway has been implicated in various diseases, including IPF. However, the role of the Hippo pathway in the pathogenesis of IPF remains unclear, particularly given the pathway’s opposing effects on the 2 key pathogenic mechanisms of IPF: epithelial cell dysfunction and fibroblast activation. A deeper understanding of the relationship between the Hippo pathway and the pathogenesis of IPF will pave the way for novel Hippo-targeted therapies.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP21ym0126007, JP21cm0106402, JP22ym0126096)
- Japan Society for the Promotion of Science (19K17649, 21H02930, 22H03082)
This publication has 93 references indexed in Scilit:
- Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)Genes & Development, 2012
- A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β‐catenin signallingThe EMBO Journal, 2012
- Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transitionProceedings of the National Academy of Sciences, 2011
- Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionJournal of Cell Biology, 2010
- Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Myofibroblast contraction activates latent TGF-β1 from the extracellular matrixJournal of Cell Biology, 2007
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences, 2006